Literature DB >> 15645152

Brain perfusion: computed tomography applications.

K A Miles1.   

Abstract

Within recent years, the broad introduction of fast multi-detector computed tomography (CT) systems and the availability of commercial software for perfusion analysis have made cerebral perfusion imaging with CT a practical technique for the clinical environment. The technique is widely available at low cost, accurate and easy to perform. Perfusion CT is particularly applicable to those clinical circumstances where patients already undergo CT for other reasons, including stroke, head injury, subarachnoid haemorrhage and radiotherapy planning. Future technical developments in multi-slice CT systems may diminish the current limitations of limited spatial coverage and radiation burden. CT perfusion imaging on combined PET-CT systems offers new opportunities to improve the evaluation of patients with cerebral ischaemia or tumours by demonstrating the relationship between cerebral blood flow and metabolism. Yet CT is often not perceived as a technique for imaging cerebral perfusion. This article reviews the use of CT for imaging cerebral perfusion, highlighting its advantages and disadvantages and draws comparisons between perfusion CT and magnetic resonance imaging.

Entities:  

Mesh:

Year:  2004        PMID: 15645152     DOI: 10.1007/s00234-004-1333-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Cerebral perfusion imaging in hemodynamic stroke: be aware of the pattern.

Authors:  R Siemund; M Cronqvist; G Andsberg; B Ramgren; L Knutsson; S Holtås
Journal:  Interv Neuroradiol       Date:  2009-12-28       Impact factor: 1.610

2.  Radiation exposure of patients in comprehensive computed tomography of the head in acute stroke.

Authors:  M Cohnen; H-J Wittsack; S Assadi; K Muskalla; A Ringelstein; L W Poll; A Saleh; U Mödder
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Cerebral perfusion computerized tomography: influence of reference vessels, regions of interest and interobserver variability.

Authors:  Jean F Soustiel; Nadav Mor; Menashe Zaaroor; Dorith Goldsher
Journal:  Neuroradiology       Date:  2006-05-23       Impact factor: 2.804

4.  Brain perfusion CT compared with ¹⁵O-H₂O PET in patients with primary brain tumours.

Authors:  Julie Marie Grüner; Rune Paamand; Michael Kosteljanetz; Helle Broholm; Liselotte Højgaard; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-27       Impact factor: 9.236

5.  Computed tomography continues to be the preferred tomographic imaging technology for patients with cardiac implantable electronic devices despite a potential risk of electrical interference by irradiation.

Authors:  Takumi Yamada
Journal:  J Nucl Cardiol       Date:  2018-03-06       Impact factor: 5.952

6.  Potential effects of low-dose average CT on cardiac implantable electronic devices.

Authors:  Emily Y Pan; Dershan Luo; Tinsu Pan
Journal:  J Nucl Cardiol       Date:  2018-01-17       Impact factor: 5.952

7.  High-concentration contrast media (HCCM) in CT angiography of the carotid system: impact on therapeutic decision making.

Authors:  Bernhard Schuknecht
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804

8.  Hyperacute stroke patients and catheter thrombolysis therapy: correlation between computed tomography perfusion maps and final infarction.

Authors:  Yukari Naito; Shigeko Tanaka; Yuichi Inoue; Shinsuke Ota; Saburo Sakaki; Hajime Kitagaki
Journal:  Radiat Med       Date:  2008-05-29

9.  Radiation dose from multidetector row CT imaging for acute stroke.

Authors:  Anisa Mnyusiwalla; Richard I Aviv; Sean P Symons
Journal:  Neuroradiology       Date:  2009-06-09       Impact factor: 2.804

10.  CT angiography and perfusion CT in cerebral vasospasm after subarachnoid hemorrhage.

Authors:  S Binaghi; M L Colleoni; P Maeder; A Uské; L Regli; A Reza Dehdashti; P Schnyder; R Meuli
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.